ATE96037T1 - Mehrphasige injizierbare emulsionen. - Google Patents

Mehrphasige injizierbare emulsionen.

Info

Publication number
ATE96037T1
ATE96037T1 AT90910772T AT90910772T ATE96037T1 AT E96037 T1 ATE96037 T1 AT E96037T1 AT 90910772 T AT90910772 T AT 90910772T AT 90910772 T AT90910772 T AT 90910772T AT E96037 T1 ATE96037 T1 AT E96037T1
Authority
AT
Austria
Prior art keywords
pct
formula
sec
active substances
representing
Prior art date
Application number
AT90910772T
Other languages
English (en)
Inventor
Bernard Brancq
Gerard Trouve
Original Assignee
Seppic Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Seppic Sa filed Critical Seppic Sa
Application granted granted Critical
Publication of ATE96037T1 publication Critical patent/ATE96037T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/113—Multiple emulsions, e.g. oil-in-water-in-oil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dispersion Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Colloid Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT90910772T 1989-07-03 1990-06-29 Mehrphasige injizierbare emulsionen. ATE96037T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR8908917A FR2649012B1 (fr) 1989-07-03 1989-07-03 Emulsions multiphasiques injectables
PCT/FR1990/000484 WO1991000106A1 (fr) 1989-07-03 1990-06-29 Emulsions multiphasiques injectables

Publications (1)

Publication Number Publication Date
ATE96037T1 true ATE96037T1 (de) 1993-11-15

Family

ID=9383409

Family Applications (1)

Application Number Title Priority Date Filing Date
AT90910772T ATE96037T1 (de) 1989-07-03 1990-06-29 Mehrphasige injizierbare emulsionen.

Country Status (12)

Country Link
US (1) US5424067A (de)
EP (1) EP0480981B1 (de)
JP (1) JP2851422B2 (de)
AT (1) ATE96037T1 (de)
AU (1) AU643690B2 (de)
BR (1) BR9007501A (de)
DE (1) DE69004094T2 (de)
DK (1) DK0480981T3 (de)
ES (1) ES2061054T3 (de)
FR (1) FR2649012B1 (de)
NZ (1) NZ234336A (de)
WO (1) WO1991000106A1 (de)

Families Citing this family (53)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2681246B1 (fr) * 1991-04-05 1995-02-10 Oreal Composition cosmetique sous forme d'emulsion triple.
CA2083553A1 (en) * 1991-11-25 1993-05-26 Kuniharu Seki Immunogen composition
FR2702373B1 (fr) * 1993-03-08 1996-06-07 Rhone Merieux Emulsions vaccinales fluides eau-dans-l'huile contenant une huile métabolisable.
FR2717694B1 (fr) * 1994-03-22 1996-05-03 Seppic Sa Une composition comprenant un plasmide recombinant et ses utilisations comme vaccin et médicament.
US5690942A (en) † 1995-06-02 1997-11-25 American Home Products Corporation Adjuvants for viral vaccines
DE69636889T2 (de) * 1995-11-30 2007-12-06 Nof Corp. Öladjuvierter Impfstoff und Verfahren zu seiner Herstellung
GB9626865D0 (en) * 1996-12-24 1997-02-12 Cyanamid Websters Pty Limited Veterinary vaccines
AU776364B2 (en) * 1996-12-24 2004-09-09 Zoetis Services Llc Veterinary vaccines
US6524592B2 (en) 1997-10-17 2003-02-25 American Home Products Corporation Veterinary vaccines
NZ503636A (en) * 1997-10-17 2002-05-31 Fort Dodge Australia Pty Vaccines for the prevention of clostridial diseases of sheep that provide effective immunity for up to a year or more from a single dose
AU769539B2 (en) * 1999-01-29 2004-01-29 Zoetis Services Llc Adjuvants for use in vaccines
FR2800280B1 (fr) * 1999-10-29 2003-09-19 Seppic Sa Nouvelle composition vaccinale et utilisation d'agents tensioactifs comme adjuvants d'immunite
JP2001131087A (ja) * 1999-11-05 2001-05-15 Chemo Sero Therapeut Res Inst オイルアジュバントワクチン
AU770475B2 (en) * 1999-12-23 2004-02-19 Aphton Corporation A stable immunogenic composition for frozen storage
FR2814956B1 (fr) 2000-10-06 2003-01-24 Seppic Sa Nouvelle composition vaccinale, procede pour sa preparation, utilisation comme composition injectale en medecine humaine ou veterinaire et nouveau procede de conservation
PT2266603E (pt) 2000-10-18 2012-11-02 Glaxosmithkline Biolog Sa Vacinas tumorais
FR2823119B1 (fr) * 2001-04-05 2004-02-20 Seppic Sa Adjuvant d'immunite contenant un cation metallique complexe et vaccin le contenant
FR2824279B1 (fr) * 2001-05-04 2004-05-28 Seppic Sa Emulsion e/h concentree
FR2824269B1 (fr) * 2001-09-03 2012-03-02 Seppic Sa Composition adjuvante constituee de 1% a 15% de tensioactifs a hlb global compris entre 5 et 8 et de 85% a 99% de corps gras
US20050158329A1 (en) * 2004-01-21 2005-07-21 Ghosh Swapan K. Novel phytol derived immunoadjuvants and their use in vaccine formulations
GB0409940D0 (en) * 2004-05-04 2004-06-09 Glaxosmithkline Biolog Sa Vaccine
AR058592A1 (es) 2005-12-22 2008-02-13 Glaxosmithkline Biolog Sa Vacuna
GB0607088D0 (en) 2006-04-07 2006-05-17 Glaxosmithkline Biolog Sa Vaccine
NZ570805A (en) 2006-03-30 2011-10-28 Glaxosmithkline Biolog Sa Vaccine comprising Type 5 and Type 8 capsular polysaccharides from Staphyloccocus aureus
US20070292521A1 (en) * 2006-06-20 2007-12-20 Schwitzer Co., Ltd Oral Encapsulated Preparation for Aquatic Animals
PT2486938T (pt) 2006-09-26 2018-06-12 Infectious Disease Res Inst Composição para vacina contendo adjuvante sintético
US20090181078A1 (en) * 2006-09-26 2009-07-16 Infectious Disease Research Institute Vaccine composition containing synthetic adjuvant
CN101883583B (zh) 2007-06-26 2017-05-17 葛兰素史密丝克莱恩生物有限公司 含有肺炎链球菌荚膜多糖缀合物的疫苗
TWI551295B (zh) 2008-04-18 2016-10-01 英特威特國際股份有限公司 防備胞內勞森菌（Ｌａｗｓｏｎｉａ ｉｎｔｒａｃｅｌｌｕｌａｒｉｓ）用疫苗
TWI494125B (zh) * 2009-06-05 2015-08-01 Infectious Disease Res Inst 合成的葡萄吡喃糖基脂質佐劑
GB0913681D0 (en) 2009-08-05 2009-09-16 Glaxosmithkline Biolog Sa Immunogenic composition
GB0913680D0 (en) 2009-08-05 2009-09-16 Glaxosmithkline Biolog Sa Immunogenic composition
EP2353609A1 (de) 2010-02-04 2011-08-10 Sanofi Pasteur Immunisierungszusammensetzungen und -verfahren
GB201003920D0 (en) 2010-03-09 2010-04-21 Glaxosmithkline Biolog Sa Method of treatment
AU2012243039B2 (en) 2011-04-08 2017-07-13 Immune Design Corp. Immunogenic compositions and methods of using the compositions for inducing humoral and cellular immune responses
WO2013083753A2 (en) 2011-12-07 2013-06-13 Institut Pasteur Identification of a swine parecho-like virus and applications
PL2811981T3 (pl) 2012-02-07 2019-09-30 Infectious Disease Research Institute Ulepszone formulacje adiuwantowe zawierające agonistę TLR4 oraz sposoby ich zastosowania
EA034351B1 (ru) 2012-05-16 2020-01-30 Иммьюн Дизайн Корп. Трехкомпонентная вакцина против впг-2 и способы ее применения
EP2877208B1 (de) 2012-07-24 2021-05-12 Sanofi Pasteur Impfstoffzusammensetzungen zur vorbeugung von dengue-virus-infektionen
JP2015524422A (ja) 2012-07-24 2015-08-24 サノフィ・パスツールＳａｎｏｆｉｐａｓｔｅｕｒ ワクチン組成物
WO2014083194A1 (en) 2012-11-30 2014-06-05 Sanofi Pasteur Methods for inducing antibodies
BR112015025709A2 (pt) 2013-04-18 2017-07-18 Immune Design Corp monoterapia com gla para uso em tratamento de câncer
US9463198B2 (en) 2013-06-04 2016-10-11 Infectious Disease Research Institute Compositions and methods for reducing or preventing metastasis
PT3089754T (pt) 2013-12-31 2021-07-23 Infectious Disease Res Inst Formulações de vacina de dose única
CN105960241A (zh) 2014-01-21 2016-09-21 免疫设计公司 用于治疗过敏性病症的组合物
US20150359880A1 (en) * 2014-06-16 2015-12-17 Biomune Company Dual adjuvant vaccine compositions, preparation and uses
AU2015252119A1 (en) 2014-11-07 2016-05-26 Takeda Vaccines, Inc. Hand, foot, and mouth vaccines and methods of manufacture and use thereof
MA40920A (fr) 2014-11-07 2017-09-12 Takeda Vaccines Inc Vaccins de la main, du pied et de la bouche, et procédés de fabrication et d'utilisation de ceux-ci
GB201518684D0 (en) 2015-10-21 2015-12-02 Glaxosmithkline Biolog Sa Vaccine
CN106267184B (zh) * 2016-03-03 2020-01-21 彭建彪 一种水包油包水型乳化剂及其用途和使用方法
CA3066915A1 (en) 2017-06-11 2018-12-20 Molecular Express, Inc. Methods and compositions for substance use disorder vaccine formulations and uses thereof
MY193736A (en) 2017-11-03 2022-10-27 Takeda Vaccines Inc Method for inactivating zika virus and for determining the completeness of inactivation
MX2021014363A (es) 2019-05-25 2022-02-21 Infectious Disease Res Inst Composicion y metodo para secar por pulverizacion una emulsion de vacuna adyuvante.

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1408437A (fr) * 1963-10-14 1965-08-13 Lummus Co Procédé de récupération du potentiel calorique d'un gaz liquéfié pendant la regazéification
GB1080994A (en) * 1963-10-25 1967-08-31 Nat Res Dev Injectable emulsions containing antigens
GB1408437A (en) * 1972-10-16 1975-10-01 C Vet Ltd Vaccines
US3983228A (en) * 1973-08-28 1976-09-28 Merck & Co., Inc. Water-in-oil adjuvant composition
US4069313A (en) * 1974-11-19 1978-01-17 Merck & Co., Inc. Water-in-oil adjuvant composition
JPS60199833A (ja) * 1984-03-26 1985-10-09 Meiji Milk Prod Co Ltd 医薬品、化粧品等用ｗ／ｏ／ｗ型複合エマルジヨンの製造法
IL74289A (en) * 1985-02-10 1989-02-28 Israel State Vaccine system comprising a live-non-virulent vaccine and an adjuvant
US4803070A (en) * 1986-04-15 1989-02-07 Ribi Immunochem Research Inc. Immunological emulsion adjuvants for polysaccharide vaccines
AU614465B2 (en) * 1989-04-05 1991-08-29 Yissum Research Development Company Of The Hebrew University Of Jerusalem Medicinal emulsions
AU648573B2 (en) * 1990-06-01 1994-04-28 Research Corporation Technologies, Inc. Self-emulsifying glasses

Also Published As

Publication number Publication date
EP0480981A1 (de) 1992-04-22
US5424067A (en) 1995-06-13
EP0480981B1 (de) 1993-10-20
WO1991000106A1 (fr) 1991-01-10
DK0480981T3 (da) 1993-11-29
AU5961090A (en) 1991-01-17
DE69004094T2 (de) 1994-02-17
JP2851422B2 (ja) 1999-01-27
ES2061054T3 (es) 1994-12-01
FR2649012B1 (fr) 1991-10-25
NZ234336A (en) 1992-07-28
AU643690B2 (en) 1993-11-25
JPH04507405A (ja) 1992-12-24
FR2649012A1 (fr) 1991-01-04
BR9007501A (pt) 1992-06-23
DE69004094D1 (de) 1993-11-25

Similar Documents

Publication Publication Date Title
ATE96037T1 (de) Mehrphasige injizierbare emulsionen.
ES2095739T4 (es) Estabilizacion de emulsiones de fluorocarbono.
FR2649013B1 (fr) Vaccins et vecteurs de principes actifs fluides contenant une huile metabolisable
BR0000126A (pt) Adjuvantes para uso em vacinas
EP0098566A3 (en) Corticoids-containing preparation for topical application
KR830002327A (ko) 약학적 제제
DE59909759D1 (de) Emulgatorfreie und bornitrid enthaltende feindisperse systeme vom typ öl-in-wasser und wasser-in-öl
NO308448B1 (no) Mikrosfærer samt fremstilling, preparater og anvendelse derav
FR2701845B1 (fr) Emulsion eau-dans-huile à usage cosmétique ou pharmaceutique.
PT99441A (pt) Processo para a preparacao de emulsoes estabilizadas de tipo oleo-em-agua con- tendo uma substancia pesticida lipofilica
NO974023D0 (no) Topisk appliserbart farmasöytisk preparat, fremgangsmåte for dets fremstilling og anvendelse derav
ES508556A0 (es) Procedimiento para la preparacion de medicamentos liposomales.
RU2000112410A (ru) Стабильные косметические композиции
DE60014162D1 (de) Fenofibrathaltige galenische arzneizusammensetzungen und verfahren zu ihrer herstellung
DE69527621D1 (de) Emulsion enthaltend eine gelierte wässerige aüssere phase, eine nichtwässerige zwischenphase und eine wässerige innere phase
TW577746B (en) Method to produce inactivated w/o emulsion adjuvated vaccines
WO2003082222A3 (de) Kosmetische oder pharmazeutische phospholipidhaltige, niedrigviskose (versprühbare) o/w-emulsionen
GR920300128T1 (en) Method for preparing a lipoprotein modified by the incorporation of a lipophilic active substance
CO4930324A1 (es) Composicion quimica que contiene un sistema preservativo y metodo para elaborar y usar tal composicion
ATE139226T1 (de) Aminosulfonylharnstoff-acat-inhibitoren
DE50009125D1 (de) Zubereitungen vom emulsionstyp w/o mit erhöhtem wassergehalt mit einem gehalt an mittelpolaren lipiden
FR2681247B1 (fr) Composition pharmaceutique pour application topique contenant du dithranol et procede de preparation.
BR9905780A (pt) Antìgenos vacinais de leptospira para prevenção da laptospirose
JPS644236A (en) Water-in-oil emulsion
Sylbert Steroids and spontaneous tendon rupture

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee